Management of Vaso-Occlusive Crisis in Sickle Cell Disease by Severity

General Management Principles

• Patients with sickle cell disease should maintain hydration with oral fluids to prevent dehydration, as they have impaired urinary concentrating ability, according to the American Society of Anesthesiologists 1, 2
• The American Society of Anesthesiologists recommends maintaining baseline hydroxyurea therapy if prescribed for patients with mild VOC 3

Pharmacologic Management by Severity

• The American Society of Anesthesiologists suggests IV hydration at maintenance rates for patients with moderate VOC 1
• Aggressive IV hydration with monitoring of fluid status is recommended for patients with severe VOC, according to the American Society of Anesthesiologists 1

Special Considerations

• Patients with HbSS and HbSβ0-thalassemia typically have more severe disease and may require more aggressive intervention, as stated by the American Society of Anesthesiologists 4, 3
• HbSC patients generally have milder symptoms but may require exchange transfusion rather than simple transfusion if needed due to higher baseline hemoglobin, according to the American Society of Anesthesiologists 4
• Acute chest syndrome requires immediate escalation to parenteral therapy regardless of initial pain severity, as recommended by the American Urological Association 5
• Priapism lasting >4 hours requires emergency urological intervention, according to the American Urological Association 5
• Patients with signs of stroke require immediate parenteral management and specialized neurological care, as stated by the American Society of Anesthesiologists 6

Monitoring Response to Treatment

• Reassess pain scores regularly using validated pain scales, as recommended by the American Society of Anesthesiologists 1
• Monitor vital signs, oxygen saturation, and mental status, according to the American Society of Anesthesiologists 1
• Assess hydration status and urine output, as recommended by the American Society of Anesthesiologists 1

Management of Vaso-Occlusive Crisis

Initial Assessment and Stabilization

• Avoid volume depletion as this can precipitate further erythrocyte sickling, according to the American Thoracic Society 7, 8
• Maintain arterial oxygen saturation ≥90% at rest with supplemental oxygen, as recommended by the American Thoracic Society 7

Critical Monitoring

• Monitor continuously for acute chest syndrome, which requires immediate escalation of care, with an incidence of 4% in children, as reported by the American Society of Hematology 9

Critical Pitfalls to Avoid

• Never use phosphodiesterase-5 inhibitors (e.g., sildenafil) as they increase hospitalization risk for vaso-occlusive crisis, according to the American Thoracic Society 7, 8
• Avoid aggressive diuresis even if volume overload develops, as volume depletion induces sickling, as warned by the American Thoracic Society 7, 8
• Use vasopressors with extreme caution if needed for other indications, as norepinephrine and epinephrine impair mucosal perfusion and could theoretically worsen ischemia, as noted by the World Society of Emergency Surgery 10

Management of Vaso-Occlusive Crisis

Hydration and Oxygenation Strategies

• Avoid volume depletion, as it can trigger further erythrocyte sickling, in patients with sickle cell disease who have impaired urinary concentrating ability, making them vulnerable to dehydration 7, 8
• Maintain arterial oxygen saturation ≥90% at rest with supplemental oxygen to prevent hypoxemia, which triggers hemoglobin polymerization and worsening sickling 7, 8

Infection Screening and Management

• Administer broad-spectrum antibiotics immediately if infection is suspected or patient appears septic, as intestinal ischemia and bacterial translocation can complicate VOC, and early antibiotic administration is critical given the high infection risk in SCD patients 10

Disease-Modifying Therapy and Monitoring

• Continue baseline hydroxyurea if the patient is already prescribed this medication, as it reduces the risk of volume depletion-induced sickling 7, 8

Common Pitfalls to Avoid

• Avoid phosphodiesterase-5 inhibitors (sildenafil, tadalafil), as they increase hospitalization risk for vaso-occlusive crisis 7, 8
• Do not use low-dose dopamine for any indication, including renal protection, due to lack of benefit 11, 12, 13
• Avoid excessive vasopressor use if hypotension develops, as norepinephrine and epinephrine impair mesenteric perfusion and may worsen ischemia 10

Management of Vaso-Occlusive Crisis in Sickle Cell Disease

Oxygenation and Monitoring

• Keep SpO2 above baseline or 96% (whichever is higher) for 24 hours or until the patient can mobilize freely, and monitor oxygen saturation continuously until it is maintained at baseline in room air 14
• Monitor continuously for acute chest syndrome, which requires immediate escalation of care, and regular monitoring of SpO2 provides early warning of acute chest syndrome 14

Temperature Management

• Maintain normothermia throughout treatment, and avoid hypothermia as this leads to shivering and peripheral stasis, causing hypoxia and increased sickling 14
• Use active warming measures including warmed fluids and increased ambient temperature, and note that a spike in temperature may be an early sign of sickling 14

Thromboprophylaxis

• Use thromboprophylaxis for all peri- and post-pubertal patients as routine, and encourage mobilization postoperatively 14
• Patients with additional risk factors (continuing immobility, previous venous thromboembolism, indwelling lines) may need special precautions 14

Critical Monitoring for Complications

• Inspect IV cannula sites regularly for phlebitis and remove immediately if signs of redness or swelling present 14
• Patients with acute life-threatening complications (acute chest syndrome, stroke, sepsis) should be admitted to intensive care and may require emergency exchange transfusion 14
• Daily assessment by a haematologist (or paediatrician if a child) is recommended after moderate or major surgery 14

Other Life-Threatening Complications

• Priapism lasting >4 hours requires emergency urological intervention 15